PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Serebruany V et al. – Chronic oral combination antiplatelet regimens are associated with a very high (56.5–60.7%) prevalence of superficial bleeding episodes, which are grossly underestimated in trials and registries. The role of such frequent mild complications for the overall benefit of antiplatelet therapy is entirely unknown, as is their effect on compliance. Although IPA is well suited for defining the risk of minor complications, prediction of more severe bleeding events may be challenging.


   

Related Articles

Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel
Thrombosis Research, 10/20/09    Relevance Score: 70%

Acidic-store depletion is required for human platelet aggregation
Blood Coagulation & Fibrinolysis, 10/05/09    Relevance Score: 69%

Platelet Aggregation in Intracranial Stents May Mimic In-Stent Restenosis
American Journal of Neuroradiology, 11/02/09    Relevance Score: 68%

The influence of low-dose aspirin and hydroxyurea on platelet-leukocyte interactions in patients with essential thrombocythemia
Blood Coagulation & Fibrinolysis, 11/03/09    Relevance Score: 66%

Thrombopoiesis in small for gestational age newborns
Platelets, 10/30/09    Relevance Score: 65%

Today in Clinical Pharmacology...keeping you current

Fibrinolytic agents for peripheral arterial occlusion
Cochrane Reviews, 03/19/10

Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise
Internal Medicine Journal, 03/19/10

Ranolazine-related dyspnea on exertion
The American Journal of Geriatric Pharmacotherapy, 03/19/10

Today in Clinical Pharmacology...keeping you current

Olanzapine versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 03/19/10

Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
Cochrane Reviews, 03/19/10

Fibrinolytic agents for peripheral arterial occlusion
Cochrane Reviews, 03/19/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address